Congenital anomalies or birth defects are defined as structural abnormalities diagnosed antenatally, at the time of birth or in the first few years of life.[@b1-asm-5-343] These often result in increased perinatal mortality, if not long-term disability in the diagnosed infant and are a burden to families, society and the healthcare system.[@b2-asm-5-343] In January 2014, the World Health Organization (WHO) reported that birth defects are estimated to affect one in every 33 infants globally and account for approximately 3.2 million birth defect-related disabilities every year.[@b2-asm-5-343]

Knowing the prevalence of birth defects and their trend is important in identifying potential novel factors that are either causative or preventative.[@b1-asm-5-343] Ultrasound examination is beneficial in the early detection of congenital malformations; in low risk populations the sensitivity is low, varying from 17% to 35 %, and the specificity is 99%, whereas in high-risk populations the sensitivity is greater than 90%.[@b2-asm-5-343] Early antenatal diagnosis of major congenital anomalies is important for the appropriate counselling of parents, possible termination of pregnancy, fetal or neonatal intervention, delivery in the appropriate centre, and future prevention.

In 2008, we reported for the first time the antenatal prevalence of major congenital anomalies in Saudi Arabia.[@b3-asm-5-343] The antenatal prevalence of major congenital anomalies within two years (2005--2006) was 27.96 per 1000 pregnancies. However, this result may significantly have under-reported the actual incidence because during that time period a large proportion of patients at King Fahad Medical City were not booked and did not have an antenatal ultrasound scan. Since this initial study we have implemented an improved screening system including a proper, antenatal booking system and follow-up of pregnant women. The goal of this study is to report on the perinatal prevalence of various types of major congenital anomalies at King Fahad Medical City covering a period of six years, from January 2007 to December 2012.

PATIENTS AND METHODS
====================

Study site and design
---------------------

This single-centre prospective study was conducted in the Obstetrics and Gynaecology Ultrasound Unit of the Maternal and Fetal Medicine Department, Women's Specialized Hospital at King Fahad Medical City, Riyadh, Saudi Arabiaa. The study site is a tertiary hospital that is the official referral centre for congenital anomalies in Saudi Arabia as appointed by the Ministry of Health. First trimester scans are routinely performed between 11 to 14 weeks of gestation, followed by early morphology scans between 16 to 17 weeks of gestation for some cases as indicated, and also morphology ultrasound examinations between 18 to 22 weeks of gestation or later upon booking, and fetal echo at 22--24 weeks. All ultrasound examinations are reviewed and reported by maternal-fetal medicine consultants. Ethical approval was obtained from the Institutional Review Board (IRB number 11--102) prior to study commencement.

Subjects
--------

A total of 63 452 obstetrical ultrasound examinations were performed for 30 632 obstetric Saudi patients from the period of January 2007 to December 2012. Subjects were excluded if the ultrasound revealed a non-viable fetus or viable fetuses with soft markers only (e.g., borderline ventriculomegaly less than 13 mm, pylectasis, short femur, choroid plexus cyst, echogenic cardiac foci, and echogenic bowel). Data were gathered from the following sources: ultrasound unit, records from the labour and delivery ward, antenatal clinics and neonatal infant care unit records. Data included demographics, ultrasound findings and other pertinent maternal and fetal information such as maternal age, maternal parity, gestational age, history of consanguinity and previous fetal anomalies. All data were entered using Microsoft Excel 2010.

Ultrasound examination and diagnosis of congenital anomalies
------------------------------------------------------------

All subjects underwent standard obstetrical ultrasound examinations based on the recommendations of the American Institute of Ultrasound in Medicine (AIUM) and the American College of Obstetricians and Gynaecologists (ACOG).[@b4-asm-5-343] The ultrasound system used was the Philips IU-22, Netherlands. Once fetal structural anomalies were identified, the following steps were taken based on the recommendations proposed by Gagnon and colleague.[@b5-asm-5-343] The pregnant woman was offered a timely consultation with a maternal-fetal medicine specialist and with a trained genetic counsellor. The counselling was unbiased and respected the patient's choice, culture, gestational age and religion (according to Saudi regulations; termination of pregnancy was allowed only before 120 days of fetal life). Ultrasound examination was repeated (at a frequency depending on the anomaly) to assess the evolution of the anomaly, but also to detect other anomalies not previously identified, as this may influence the counselling as well as the obstetrical or perinatal management. Once a fetal structural anomaly was identified by 2-D ultrasound, other imaging techniques such as fetal echocardiography, 3-D obstetrical ultrasound, and occasionally fetal MRI were considered in specific cases, depending on the fetal anomaly identified.

To diagnose a potential genetic anomaly of a fetus with isolated or multiple structural anomalies, prenatal invasive testing for karyotyping was performed. Chorionic villus sampling (CVS), amniocentesis or cordocentesis was performed in females who gave consent for a fetal anomaly that required karyotyping. Women received the information on the abnormal ultrasound findings in a clear and timely fashion, and in a supportive environment that ensured privacy. Parents were referred to the appropriate pediatric or surgical subspecialist(s) to receive accurate information concerning the anomaly or anomalies of the fetus and the associated prognosis. Parents were informed that major or minor fetal structural anomalies, whether isolated or multiple, may be part of a genetic syndrome, sequence, or association, despite a normal fetal karyotype. If early or urgent postnatal management was required, delivery at a centre that could provide the appropriate neonatal care was considered. A comprehensive clinical assessment of the newborn was essential for diagnosis and counselling on the etiology, prognosis, and recurrence risk for future pregnancies. In cases of termination of pregnancy, stillbirth, or neonatal death, the option for an autopsy was offered, which was, however, declined in the majority of cases.

Data analysis
-------------

The antenatal prevalence was calculate per 1000 pregnancies, and birth prevalence was calculate per 1000 live births.

RESULTS
=======

During the study period, 30 632 pregnant women were screened. We diagnosed and managed 1598 cases of major congenital anomalies, including 1064 (66.58%) fetuses with isolated congenital anomalies and 534 (33.42%) fetuses with non-isolated (multiple) congenital anomalies. The antenatal prevalence of major congenital anomalies was 52.17 per 1000 pregnancies. The median maternal age at diagnosis was 29 years, the median maternal parity was one, and the median gestational age at diagnosis was 30 weeks of gestational age ([Figure 1](#f1-asm-5-343){ref-type="fig"}).

Of 1598 cases of major congenital anomalies, 67 (4.19%) patients underwent termination of pregnancy, 1351 (84.54%) patients delivered in our institution, and 180 (11.27%) patients were either lost to follow-up or referred back to their primary healthcare centres. During the study period the number of live births was 29,084 and the birth prevalence of major congenital anomalies was 46.45 per 1,000 live births. The median gestational age at delivery was 38 weeks of gestation. Genitourinary system anomalies were the most common, with 652 cases diagnosed and 576 delivered. The second most common identified birth defects were skeletal anomalies with 417 cases diagnosed and 353 cases delivered. The occurrence of anomalies in other systems as well as maternal and fetal characteristics for these cases are shown in [Table 1](#t1-asm-5-343){ref-type="table"}. The percentage of isolated anomalies was highest in the genitourinary system group (n=500, 76.7%) followed by neural tube defects (NTD) (n=79, 41.8%), whereas the percentage of non-isolated anomalies was highest in the face and neck (n=195, 84.4%), followed by the skeletal system group (n=312, 74.8%).

Karyotyping was performed in females who gave consent ([Table 2](#t2-asm-5-343){ref-type="table"}). In 267 karyotypes, 65 cases had abnormal results with trisomy 18 being the most common finding (n=23) followed by trisomy 21 (n=14), trisomy 13 (n=11), and monosomy X (n=9).

The most common congenital abnormalities were in the genitourinary system (652 cases) with an antenatal prevalence of 21.28 per 1000 pregnancies and a birth prevalence of 19.80 per 1000 live births. In the genitourinary system, the leading anomaly was hydro-nephrosis (either unilateral or bilateral) with 266 cases; the antenatal prevalence and birth prevalence were with 8.7 and 8.5, respectively. For the cranial anomalies, ventriculomegaly (either mild less than 15 mm or severe more than 15 mm), was the most frequently diagnosed anomaly (259 cases of 415 cases of cranial anomalies); the antenatal and birth prevalence of ventriculomegaly were 8.5 and 7.7, respectively ([Table 3](#t3-asm-5-343){ref-type="table"}). Further details of antenatal and birth prevalence of other systems are shown in [Table 3](#t3-asm-5-343){ref-type="table"}. The consanguinity rate was 37.86% (605 of 1598 cases) ([Table 4](#t4-asm-5-343){ref-type="table"}). In some cases, structural anomalies were associated with a previous family history with a variable incidence per system group.

[Tables 5](#t5-asm-5-343){ref-type="table"} and [6](#t6-asm-5-343){ref-type="table"} show factors associated with consanguinity, and ultrasonographic findings and neonatal outcomes.

DISCUSSION
==========

The antenatal prevalence of major congenital anomalies was 52.17 per 1000 pregnancies and the birth prevalence of major congenital anomalies was 46.45 per 1000 live births. Genitourinary system anomalies were the most commonly identified anomalies because renal defects are usually easy to diagnose in comparison to other systems such as cardiac and cranial anomalies. The consanguinity rate of 37.9% was high. The diagnosis of major congenital anomalies has improved dramatically in the past few years and is mainly attributable to advancements in ultrasound systems technology, which are also being operated by skilled sonographers and perinatologists. This may explain the increased number of cases currently being diagnosed compared to the past, which consequently reflects a higher prevalence and incidence of congenital anomalies. The management of birth defects has also improved in terms of an early diagnosis and termination of pregnancy if needed as well as post-natal care of newborns by a skilled neonatal intensive care unit team in tertiary care centres.[@b3-asm-5-343]

The main finding of the present study is the relatively high prevalence of congenital anomalies in the KFMC population, more specifically 52.1 cases per 1000 pregnancies and 46.5 cases per 1000 live births. This occurrence is higher than previously reported in 2008, when the antenatal prevalence of major congenital anomalies within two years (2005 and 2006) was found to be 27.96 per 1000 pregnancies.[@b5-asm-5-343] However, these results may be significantly compromised by the fact that during that period of time, a large proportion of our patients were not booked for an antenatal ultrasound scan.

The prevalence of birth defects in Saudi Arabia reported in this study is considerably higher compared to other countries. EUROCAT, the European Surveillance of Congenital Anomalies, reported a prevalence of 23.9 per 1000 births in Europe for 2003--2007.[@b6-asm-5-343] The Centres for Disease Control and Prevention (CDC) in the United States reported that approximately 3% of all live births are complicated with congenital abnormalities.[@b7-asm-5-343]

This high incidence of birth defects in the country may largely be attributed to consanguinity, a well-established major risk factor for congenital anomaly.[@b8-asm-5-343] On a regional level, the increased risk for congenital anomalies secondary to consanguinity has already been observed from recent Middle-Eastern and North African studies with similarly high incidence of consanguineous marriages.[@b9-asm-5-343]--[@b11-asm-5-343] The present findings are no exception, with a rate of consanguinity of almost 40% for the congenital anomalies cohort.

There is growing evidence of a link between maternal prenatal environmental exposures and an increased risk of congenital abnormalities. More specifically, epidemiological studies have shown that exposure during pregnancy to environmental factors including tobacco smoke, outdoor air pollution (e.g. PM~10~, NO~2~, and SO~2~), water contaminated with chlorination disinfection byproducts and pesticides, is significantly associated with an increased risk of congenital abnormalities. [@b12-asm-5-343]--[@b15-asm-5-343] As a result of the recent urbanization and in dustrialization that has taken place in Saudi Arabia, the levels of air and water pollution have increased substantially. Therefore, such environmental factors may partly explain the high prevalence of congenital abnormalities in Saudi Arabia.

Vitamin deficiencies could also explain the increased prevalence of congenital abnormalities in Saudi Arabia. Prenatal folic acid deficiency is correlated with neural tube defects, a very common congenital abnormality. A recent cross-sectional study among 1000 Saudi females 18--45 years old showed that only 4.4% of these took folic acid before pregnancy.[@b16-asm-5-343] Increasing awareness of the benefits of folic acid prenatal supplementation, especially among less educated women, may contribute towards decreasing the prevalence of neural tube defects in Saudi Arabia.

Additional risk factors identified in Western countries include an increased maternal age,[@b17-asm-5-343],[@b18-asm-5-343] maternal age lower than 25 years and non-Hispanic white maternal ethnicity,[@b19-asm-5-343] as well as maternal smoking history.[@b20-asm-5-343] These risk factors, which were not assessed in the present study, are worthy of future investigation to determine whether they contribute to the high incidence of birth defects in Saudi Arabia.

Our study has several important limitations. A Saudi Registry for Congenital Anomalies is still not available. Despite the large sample size, the present study is limited because it did not include more centres across the country. Furthermore, our database has no information on the regional distribution of the subjects. If this was available, we would be able to observe regional variations in anomalies across the country. Furthermore, we have no information on anomalies seen in other centers. We can estimate the incidence of congenital anomalies in our KFMC population, which may or may not be generalizable to the Saudi population. Another limitation is that we have a referral population that may artificially inflate the prevalence of anomalies. In addition, late referral and diagnosis of fetal anomalies is a challenging issue that significantly affects perinatal outcomes. We encourage all patients and doctors to have early antenatal care and referrals, as well as control of pregnancy termination.

CONCLUSION
==========

The prevalence of major congenital anomalies in KFMC was found to be higher than that reported for international data. The high rate of consanguinity may partly explain this high prevalence. Creating a Saudi Registry for Congenital Anomalies as well as a database for the regional distributions of fetal anomalies is warranted.
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###### 

Cases of congenital anomalies per system, with maternal and fetal characteristics.

  System          Total cases   Mean parity   Mean maternal age   Mean GA at diagnosis   Isolated (%)   Non-Isolated (%)   Total deliveries   Delivery GA   Male Fetus (%)   Female Fetus (%)   NICU (%)      NND (%)      Consanguinity (%)   Family History (%)
  --------------- ------------- ------------- ------------------- ---------------------- -------------- ------------------ ------------------ ------------- ---------------- ------------------ ------------- ------------ ------------------- --------------------
  Cranial         415           2             29                  31                     155 (37.3)     260 (62.7)         365                38            145 (39.7)       148 (40.5)         160 (43.8 )   142 (38.9)   151 (36.4)          66 (15.9)
  NTD             189           1             28                  27                     79 (41.8)      110 (58.2)         149                37            46 (30.1)        77 (51.7)          66 (44.3)     86 (57.7)    59 (31.2)           23 (12.3)
  Face and neck   231           2             30                  28                     36 (15.6)      195 (84.4)         187                36            84 (44.9)        70 (37.4)          63 (33.7)     117 (62.6)   85 (36.8)           40 (17.3)
  Thorax          180           2             28                  27                     31 (17.2)      149 (82.8)         146                32            66 (45.2)        56 (38.6)          38 (26.0)     107 (73.3)   74 (41.1)           35 (19.4)
  Cardiac         245           2             30                  30                     96 (39.2)      149 (60.8)         199                37            72 (36.2)        87 (43.7)          84 (42.2)     80 (40.2)    58 (23.7)           34 (13.9 )
  Abdomen         275           1             28                  28                     84 (30.5)      191 (69.5)         236                34            96 (40.7)        91 (38.6)          69 (29.2)     134 (56.8)   100 (36.4)          41 (14.9)
  GUS             652           1             29                  32                     500 (76.7)     152 (23.3)         576                38            307 (53.3)       144 (25)           121 (21)      162 (28.1)   201 (30.1)          78 (11.9)
  Skeletal        417           2             28                  29                     105 (25.2)     312 (74.8)         353                36            156 (44.2)       127 (36)           109 (0.9)     187 (53)     159 (38.1)          76 (18.2)

NTD: Neural Tube Defect, GUS: Genitourinary System, GA: Gestational Age, NICU: Neonatal Intensive Care Unit, NND: Neonatal Death

###### 

Karyotyping results for study population.

  System          Total cases   Karyotyped cases   Cases with abnormal karyotype, (%)   Trisomy 18, (%)   Trisomy 13, (%)   Trisomy 21, (%)   Turner syndrome, (%)   Other, (%)
  --------------- ------------- ------------------ ------------------------------------ ----------------- ----------------- ----------------- ---------------------- ------------
  Cranial         415           117                29 (6.99)                            10 (2.41)         9 (2.17)          5 (1.2)           1 (0.24)               4 (2.76)
  NTD             189           21                 1 (0.53)                             1 (053)           0 (0)             0 (0)             0 (0)                  0 (0)
  Face and Neck   231           117                42 (18.18)                           16 (6.93)         10 (4.33)         7 (3.03)          7 (3.03)               2 (087)
  Thorax          180           66                 13 (7.22)                            16 (8.89)         1 (056)           3 (1.67)          6 (3.33)               0 (0)
  Cardiac         245           76                 31 (12.65)                           10 (4.08)         8 (3.27)          6 (2.45)          3 (1.22)               4 (1.63)
  Abdomen         275           98                 23 (8.36)                            14 (5.09)         4 (1.45)          8 (2.91)          3 (1.09)               1 (0.36)
  GUS             652           55                 14 (2.15)                            6 (0.92)          3 (0.46)          1 (0.15)          1 (0.15)               3 (0.46)
  Skeletal        417           119                29 (6.95)                            14 (3.36)         2 (0.48)          5 (1.19)          6 (1.44)               2 (0.48)

NTD: Neural tube defect, GUS: Genitourinary system

###### 

Outcome of cases with congenital anomalies.

  System          Total cases   Diagnosis                    Number   Abortion \<23 week   Delivery \>23 week   Lost to follow-up   Antenatal prevalence (per 1000 pregnancies)   Birth prevalence (per 1000 live births)
  --------------- ------------- ---------------------------- -------- -------------------- -------------------- ------------------- --------------------------------------------- -----------------------------------------
  Cranial         415                                        415      8                    365                  42                  13.55                                         12.55
                                Ventriculiomegaly            156      2                    137                  17                  5.1                                           4.7
                                Hydrocephalus                103      2                    88                   13                  3.4                                           3.0
                                Holoprosence-phaly           28       0                    26                   2                   0.9                                           0.9
                                Dandy Walker                 33       1                    30                   2                   1.1                                           1.0
                                                                                                                                                                                  
  NTD             189                                        189      28                   149                  12                  6.17                                          5.12
                                Anencephaly                  62       22                   37                   3                   2.0                                           1.3
                                Encephalocele                46       4                    39                   3                   1.5                                           1.3
                                Spina Bifida                 87       3                    77                   7                   2.8                                           2.6
                                                                                                                                                                                  
  Face and neck   231                                        231      15                   187                  29                  7.54                                          6.43
                                Cleft lip and/or palate      45       1                    37                   7                   1.5                                           1.3
                                Cystic hygroma               49       11                   32                   6                   1.6                                           1.1
                                                                                                                                                                                  
  Thorax          180                                        180      11                   146                  23                  5.88                                          5.02
                                Diaphragmatic hernia         33       0                    26                   7                   1.1                                           0.9
                                Hydrops                      117      11                   95                   11                  3.8                                           3.3
                                                                                                                                                                                  
  Cardiac         245                                        245      6                    199                  40                  8.00                                          6.84
                                VSD                          84       1                    71                   12                  2.7                                           2.4
                                AVSD                         28       1                    23                   4                   0.9                                           0.8
                                HPLH                         18       0                    14                   4                   0.6                                           0.5
                                TGA                          11       0                    7                    4                   0.36                                          0.2
                                                                                                                                                                                  
  Abdomen         275                                        275      16                   236                  23                  8.98                                          9.46
                                Doudenal Atresia             9        0                    7                    2                   0.3                                           0.2
                                Omphalocele                  21       3                    16                   2                   0.7                                           0.7
                                LBWC                         12       3                    8                    1                   0.4                                           0.28
                                Gastoschiasis                2        0                    2                    0                   0.065                                         0.069
                                                                                                                                                                                  
  GUS             652                                        652      14                   576                  62                  21.28                                         19.80
                                Renal agenesis-B             68       3                    54                   11                  2.2                                           1.86
                                Renal agenesis unilateral    40                            37                                       1.3                                           1.3
                                Hydronephrosis - Right       104      2                    97                   5                   3.4                                           3.3
                                Hydronephrosis - Left        83       0                    76                   7                   2.7                                           2.6
                                Hydronephrosis - Bilateral   79       0                    76                   3                   2.6                                           2.6
                                Multicystic bilateral        48       1                    41                   6                   1.6                                           1.4
                                Multicystic unilateral       38       0                    35                   3                   1.2                                           1.2
                                Polycystic                   58       4                    44                   10                  1.9                                           1.5
                                PUV                          36       0                    31                   5                   1.2                                           1.06
                                                                                                                                                                                  
  Skeletal        417                                        417      24                   353                  40                  13.61                                         12.14
                                Thanatophoric dysplasia      8        0                    7                    1                   0.261                                         0.241
                                Achondrogenesis              7        2                    5                    0                   0.229                                         0.172
                                OI type II                   10       1                    8                    1                   0.301                                         .0275
                                Achondroplasia               17       0                    14                   3                   0.555                                         0.481
                                Arthrogryposis               16       0                    12                   4                   .0526                                         .0413

NTD: Neural tube defect, VSD: Ventricular septal defect, AVSD: Atrio-ventricular septal defect, HPLH: hypoplastic left heart, TGA: transposition of great arteries. LBMC: limb-body wall complex, GUS: Genito-urinary system, PUV: posterior urethral valve, OI: osteogenesis imperfecta

###### 

Consanguinity by patient characteristics.

                                                                Non-consanguineous    Consanguineous        Total                 *P*                  
  -------------------------------------- ---------------------- --------------------- --------------------- --------------------- ------ ------ ------ --------
  Nationality                            Non-Saudi              25                    71.4                  10                    28.6   35     2.5    .040
  Saudi                                  746                    53.9                  637                   46.1                  1383   97.5          
                                                                                                                                                       
  Age (y)                                Mean (SD) (min, max)   29.8 (6.0) (16, 49)   28.6 (6.0) (16, 53)   29.2 (6.0) (16, 53)   .001                 
  16 to 24                               157                    46.7                  179                   53.3                  336    24.0          
  25 to 53                               614                    56.7                  468                   43.3                  1082   76.0          
                                                                                                                                                       
  History family                                                93                    36.6                  161                   63.4   254    17.9   \<.001
                                                                                                                                                       
  Diabetes mellitus                      Type 1                 35                    47.9                  38                    52.1   73     5.1    .272
  Type 2                                 44                     48.9                  46                    51.1                  90     6.3           
                                                                                                                                                       
  Gestation age at presentation (week)   ≤22                    156                   54.4                  131                   45.6   287    20.2   .995
  ≥23                                    615                    54.4                  516                   45.6                  1131   79.8          
                                                                                                                                                       
  Parity                                 Nulliparous            225                   55.1                  183                   44.9   408    28.8   .710
  Multi parous                           546                    54.1                  464                   45.9                  1010   71.2          
                                                                                                                                                       
  Previous anomalies                                            235                   54.7                  195                   45.3   430    30.3   .889

###### 

Factors associated with consanguinity.

  Characteristic              OR     95% CI           *P*
  --------------------------- ------ ---------------- --------
  Nationality (Saudi)         2.22   (4.76 -- 1.02)   .045
  Age (16 to 24)              1.56   (2.04 -- 1.22)   \<.001
  Family History              2.33   (3.13 -- 1.75)   \<.001
  Number of Anomalies (\>1)   1.52   (1.89 -- 1.22)   \<.001

###### 

Ultrasonographic findings and neonatal outcome by consanguinity.

                                                            Non-Consanguineous   Consanguineous   Total   *P*                  
  ---------------------------------- ---------------------- -------------------- ---------------- ------- ------ ------ ------ --------
  Number of anomalies                One                    392                  50.8             253     39.1   645    45.5   \<.001
  \> One                             379                    49.2                 394              60.9    773    54.5          
  median (min, max)                  1 (1,7)                2 (2,8)              1 (1,8)                                       
                                                                                                                               
  Major congenital anomalies         Isolated (Single)      544                  70.6             402     62.1   946    66.7   .001
  Non-isolated (Multiple)            227                    29.4                 245              37.9    472    33.3          
                                                                                                                               
  Status                             Terminated Pregnancy   37                   4.8              30      4.6    67     4.7    .886
  Delivered                          734                    95.2                 617              95.4    1351   95.3          
                                                                                                                               
  Gestation age at delivery (week)   23 to 28               41                   5.6              31      5.0    72     5.3    .294
  29 to 36                           182                    24.8                 176              28.5    358    26.5          
  37 to 42                           511                    69.6                 410              66.5    921    68.2          
                                                                                                                               
  Delivery type                      Term                   511                  69.6             410     66.5   921    68.2   .213
  Preterm                            223                    30.4                 207              33.5    430    31.8          
                                                                                                                               
  Gender of baby                     Female                 349                  45.3             299     46.2   648    45.7   .738
  Male                               421                    54.7                 348              53.8    769    54.3          
                                                                                                                               
  NICU admission                                            277                  37.7             251     40.7   528    39.1   .270
                                                                                                                               
  Neonatal outcome                   Survived               240                  32.7             260     42.1   500    37.0   \<.001
